Brian Andrew Mitchell

US·SEC (Form 4)

GenMark Diagnostics, Inc.

Cumul. flow

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (50 ops.)

€1.4M

Latest filing published 10 Sept 2020 for GenMark Diagnostics, Inc., €37k.

Filing timeline

BuySale

Brian Andrew Mitchell

Insider track record

Disclosed buys

Disclosed sells

Signal history

Brian Andrew Mitchell: trading record in brief

All filings by Brian Andrew Mitchell on record concern GenMark Diagnostics, Inc. The record holds 56 filings, for trades running from 2 November 2017 to 8 September 2020.

Sales make up the whole of the open-market record (50 sales, €1.4M). Besides market trades, the filings include 4 share grants and 2 option exercises. 2020 to date brings no purchases and 25 sales.

The latest filing, published on 10 September 2020, reports an open-market sale of €37k in GenMark Diagnostics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Brian Andrew Mitchell

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

GenMark Diagnostics, Inc. (US)

Declarations56 total

▼
Brian Andrew Mitchell
SVP, OperationsExecutives8 Sept 2020GenMark Diagnostics, Inc.
44,080 USD29SEC
4,000 shares@ US$11.023.2% of flowCommon StockSEC:0001487371-20-000291:0
▼
Brian Andrew Mitchell
SVP, OperationsExecutives25 Aug 2020GenMark Diagnostics, Inc.
29,454 USD29SEC
2,083 shares@ US$14.142.1% of flowCommon StockSEC:0001487371-20-000283:0
▼
Brian Andrew Mitchell
SVP, OperationsExecutives26 Aug 2020GenMark Diagnostics, Inc.
51,059 USD29SEC
3,464 shares@ US$14.743.7% of flowCommon StockSEC:0001487371-20-000283:1
▼
Brian Andrew Mitchell
SVP, OperationsExecutives20 Aug 2020GenMark Diagnostics, Inc.
26,058 USD29SEC
1,691 shares@ US$15.411.9% of flowCommon StockSEC:0001487371-20-000262:0
▼
Brian Andrew Mitchell
SVP, OperationsExecutives21 Aug 2020GenMark Diagnostics, Inc.
46,813 USD29SEC
2,997 shares@ US$15.623.4% of flowCommon StockSEC:0001487371-20-000262:1
▼
Brian Andrew Mitchell
SVP, OperationsExecutives18 Aug 2020GenMark Diagnostics, Inc.
6,657 USD29SEC
420 shares@ US$15.850.5% of flowCommon StockSEC:0001487371-20-000249:0
▼
Brian Andrew Mitchell
SVP, OperationsExecutives19 Aug 2020GenMark Diagnostics, Inc.
696,553 USD34SEC
44,881 shares@ US$15.5250.4% of flowCommon StockSEC:0001487371-20-000249:1
▼
Brian Andrew Mitchell
SVP, OperationsExecutives4 Aug 2020GenMark Diagnostics, Inc.
11,756 USD29SEC
621 shares@ US$18.930.9% of flowCommon StockSEC:0001487371-20-000235:0
▼
Brian Andrew Mitchell
SVP, OperationsExecutives3 Aug 2020GenMark Diagnostics, Inc.
71,680 USD30SEC
4,000 shares@ US$17.925.2% of flowCommon StockSEC:0001487371-20-000224:0
▼
Brian Andrew Mitchell
SVP, OperationsExecutives1 Jul 2020GenMark Diagnostics, Inc.
57,800 USD23SEC
4,000 shares@ US$14.454.4% of flowCommon StockSEC:0001487371-20-000207:0
▼
Brian Andrew Mitchell
SVP, OperationsExecutives1 Jun 2020GenMark Diagnostics, Inc.
38,880 USD29SEC
4,000 shares@ US$9.723.0% of flowCommon StockSEC:0001487371-20-000203:0
▼
Brian Andrew Mitchell
SVP, OperationsExecutives28 May 2020GenMark Diagnostics, Inc.
19,240 USD29SEC
2,021 shares@ US$9.521.5% of flowCommon StockSEC:0001487371-20-000186:0
▼
Brian Andrew Mitchell
SVP, OperationsExecutives19 May 2020GenMark Diagnostics, Inc.
22,290 USD29SEC
2,131 shares@ US$10.461.7% of flowCommon StockSEC:0001487371-20-000160:0
▼
Brian Andrew Mitchell
SVP, OperationsExecutives5 May 2020GenMark Diagnostics, Inc.
9,483 USD29SEC
703 shares@ US$13.490.7% of flowCommon StockSEC:0001487371-20-000142:0
▼
Brian Andrew Mitchell
SVP, OperationsExecutives1 May 2020GenMark Diagnostics, Inc.
49,760 USD29SEC
4,000 shares@ US$12.443.9% of flowCommon StockSEC:0001487371-20-000138:0
▼
Brian Andrew Mitchell
SVP, OperationsExecutives20 Apr 2020GenMark Diagnostics, Inc.
64,000 USD11SEC
8,000 shares@ US$8.005.0% of flowCommon StockSEC:0001487371-20-000112:0
▼
Brian Andrew Mitchell
SVP, OperationsExecutives1 Apr 2020GenMark Diagnostics, Inc.
7,980 USD11SEC
2,000 shares@ US$3.990.6% of flowCommon StockSEC:0001487371-20-000100:0
▼
Brian Andrew Mitchell
SVP, OperationsExecutives2 Mar 2020GenMark Diagnostics, Inc.
7,000 USD29SEC
2,000 shares@ US$3.500.5% of flowCommon StockSEC:0001487371-20-000090:0
▼
Brian Andrew Mitchell
SVP, OperationsExecutives27 Feb 2020GenMark Diagnostics, Inc.
6,974 USD29SEC
1,987 shares@ US$3.510.5% of flowCommon StockSEC:0001487371-20-000078:0
▼
Brian Andrew Mitchell
SVP, OperationsExecutives25 Feb 2020GenMark Diagnostics, Inc.
884 USD29SEC
232 shares@ US$3.810.1% of flowCommon StockSEC:0001487371-20-000061:2
◆
Brian Andrew Mitchell
SVP, OperationsExecutives25 Feb 2020GenMark Diagnostics, Inc.
0SEC
33,750 shares0Common StockSEC:0001487371-20-000061:0
◆
Brian Andrew Mitchell
SVP, OperationsExecutives25 Feb 2020GenMark Diagnostics, Inc.
0SEC
33,750 shares0Common StockSEC:0001487371-20-000061:1
▼
Brian Andrew Mitchell
SVP, OperationsExecutives20 Feb 2020GenMark Diagnostics, Inc.
30,989 USD29SEC
8,155 shares@ US$3.802.4% of flowCommon StockSEC:0001487371-20-000037:0
▼
Brian Andrew Mitchell
SVP, OperationsExecutives4 Feb 2020GenMark Diagnostics, Inc.
4,212 USD29SEC
780 shares@ US$5.400.3% of flowCommon StockSEC:0001487371-20-000030:0
▼
Brian Andrew Mitchell
SVP, OperationsExecutives3 Feb 2020GenMark Diagnostics, Inc.
10,820 USD29SEC
2,000 shares@ US$5.410.7% of flowCommon StockSEC:0001487371-20-000028:0

25 of 56 declarations

Brian Andrew Mitchell

Insider track record

Brian Andrew Mitchell: trading record in brief

Companies and markets linked to Brian Andrew Mitchell

Similar companies

Related executives